Clinical Endocrinology · 2007 · 130 citations · 32 references
MedicineMolecular BiologyOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer Molecular PathologyCancer TranscriptomicsThyroid CancerThyroid DisordersThyroid ImagingThyroid Uptake StudiesBraf V600 MutationsBraf V600e MutationIodide UptakeIodine-131 Therapy ImagingProtein Expression LevelsThyroid Cancer GeneticsThyroid Cancer PathologyThyroid Radionuclide Uptake
OBJECTIVE: Papillary thyroid cancers (PTCs) with no iodine uptake have an aggressive behaviour and a poor prognosis. The aim of our study was to characterize, at molecular level, a subset of PTC with no 131 iodine ((131)I) uptake. DESIGN AND METHODS: Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups. RESULTS: Cancers with no (131)I uptake had slightly reduced NIS, significantly reduced thyroglobulin (P < 0.01), thyroperoxidase (P = 0.01) and pendrin (P = 0.03) and significantly increased GLUT-1 (P = 0.01) gene expression levels; and a high frequency of BRAF mutations (77%). BRAF(V600E) mutation, in both primary and metastatic thyroid cancers, is associated with a marked drop in thyroperoxidase (29-fold) and pendrin (20-fold) expression and a considerable increase (five-fold) in GLUT-1 expression. CONCLUSIONS: (1) The loss of (131)I uptake in recurrences depends not only on a decrease in NIS gene, but possibly on a reduction in the molecules regulating its intracellular metabolism; (2) the high GLUT-1 gene expression supports the use of positron emission tomography with specific tracers in clinical management of such cancers; and (3) BRAF(V600E) point mutations may lead to less differentiated phenotypes, suggesting a worse prognosis.
32
Cloning and characterization of the thyroid iodide transporter
Ge Dai, Orlie Levy, Nancy Carrasco · Nature · 1996 · 1.1K citations
Marina N. Nikiforova, Edna Teruko Kimura, Manoj Gandhi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 1.1K citations · Full text
Richard J. Robbins, Qiang Wan, Ravinder K. Grewal et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 585 citations
Medicine, Nuclear Medicine, Oncology +17
Sepehr Eskandari, Donald D. F. Loo, Ge Dai et al. · Journal of Biological Chemistry · 1997 · 462 citations · Full text